Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome
Background and Objectives: Phenibut (4-amino-3-phenyl-butyric acid), acting as a GABA-B receptor agonist, has a beneficial effect on anxiety. Although its medical use is not approved in western countries, it can be easily obtained worldwide via the Internet, so it spread as a substance of abuse. In...
Saved in:
Published in: | Frontiers in psychiatry Vol. 12 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Frontiers Media S.A
28-06-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and Objectives:
Phenibut (4-amino-3-phenyl-butyric acid), acting as a GABA-B receptor agonist, has a beneficial effect on anxiety. Although its medical use is not approved in western countries, it can be easily obtained worldwide
via
the Internet, so it spread as a substance of abuse. In recent years, some case reports have, therefore, highlighted episodes of acute toxicity or withdrawal, but it is still a largely unknown phenomenon.
Methods:
In this case report, a 50-year-old woman was admitted to the emergency room with psychomotor agitation, psychotic symptoms, and insomnia, and was non-responsive to treatment. She was hospitalized at the psychiatry ward for 25 days and gave her consent for the publication of the present case report.
Results:
The suspicion of phenibut withdrawal allowed to establish the appropriate management, leading to the
restitutio ad integrum
of the psychopathological case.
Conclusions:
In the face of an incoercible psychomotor agitation case, the knowledge of the so-called novel psychoactive substances allows for more appropriate clinical management of intoxication and withdrawal syndromes. This is a scientifically significant report as it provides therapeutic and outcome data concerning a syndrome that is still quite unfamiliar. |
---|---|
Bibliography: | This article was submitted to Addictive Disorders, a section of the journal Frontiers in Psychiatry Edited by: Giuseppe Bersani, Sapienza University of Rome, Italy Reviewed by: Domenico De Berardis, Azienda Usl Teramo, Italy; Fabrizio Schifano, University of Hertfordshire, United Kingdom; Jolanta B. Zawilska, Medical University of Lodz, Poland |
ISSN: | 1664-0640 1664-0640 |
DOI: | 10.3389/fpsyt.2021.688147 |